NEUNEUREN PHARMACEUTICALS LIMITED

Appendix 4G

Date and time
Announcement type
Company Administration

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV

Appendix 4G – NEU ASX Announcement | Bold Investors